Clinical Trial Update: PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing polyethylene glycol (PEG) to lactulose for treatment of overt hepatic encephalopathy. Status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Hepatic Encephalopathy | Phase 4 | Status: UNKNOWN